This Current Report on Form8-K does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Asset Purchase Agreement
As previously announced, also on May 8, 2019, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with E&C FinFan, Inc., a Delaware corporation (the “Acquiror”), and, solely to guarantee the performance of the Acquiror’s obligations thereunder, Chart Industries, Inc., a Delaware Corporation (“Chart”). Upon the terms and subject to the conditions of the Asset Purchase Agreement, the Company has agreed to sell, and the Acquiror has agreed to acquire, the Company’s IndustrialAir-X-Changers business (the “Business”) for aggregate cash consideration of $592 million, which is subject to adjustment based on the working capital balance of the Business at the time of the closing, plus the assumption by the Acquiror of the liabilities of the Business specified in the Asset Purchase Agreement.
Each party’s obligation to consummate the transactions contemplated by the Asset Purchase Agreement is subject to certain conditions, including (i) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; (ii) the absence of any law or order issued by any governmental authority preventing consummation of any of the transactions contemplated by the Asset Purchase Agreement; and (iii) subject to certain exceptions, the accuracy of the representations and warranties of, and compliance with covenants by, each of the parties to the Asset Purchase Agreement. The Acquiror’s obligation to consummate the transactions contemplated by the Asset Purchase Agreement is also conditioned on, among other things, the absence of the occurrence of a Material Adverse Effect (as defined in the Asset Purchase Agreement) with respect to the Business.
The Asset Purchase Agreement contains certain representations, warranties and covenants made by both parties. The Asset Purchase Agreement also contains termination rights for each of the Company and the Acquiror, including the right to terminate if the transactions contemplated by the Asset Purchase Agreement have not been completed by February 8, 2020, which date may be extended by either party to May 8, 2020 under the circumstances specified in the Asset Purchase Agreement.
The foregoing descriptions of the Stock Purchase Agreement, the Asset Purchase Agreement and the transactions contemplated by each agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Stock Purchase Agreement and the Asset Purchase Agreement, which are attached hereto as Exhibit 2.1 and Exhibit 2.2, respectively, and incorporated herein by reference.
The Stock Purchase Agreement and the Asset Purchase Agreement have been attached as exhibits to this report in order to provide investors and security holders with information regarding their respective terms. They are not intended to provide any other factual information about the Company, Buyer, Sellers, the Sellers’ Representative, the Business, the Acquiror, Chart or their respective subsidiaries and affiliates. The representations, warranties and covenants contained in the Stock Purchase Agreement and the Asset Purchase Agreement were made only for purposes of the relevant agreement and as of specific dates as set forth therein; are solely for the benefit of the parties to the applicable agreement; may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the applicable agreement; may have been made for the purposes of allocating contractual risk between the parties to the applicable agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the parties that differ from those applicable to investors. Investors should not rely on the representations, warranties or covenants or any description thereof as characterizations of the actual state of facts or condition of the Company, Buyer, Sellers, the Sellers’ Representative, the Business, the Acquiror, Chart or their respective subsidiaries and affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the applicable agreement, which subsequent information may or may not be fully reflected in public disclosures by the Company.